73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

February 2024Lara C. Pullen, PhDResults from a contemporary standard-of-care study of patients with primary hemophagocytic lymphohistiocytosis (pHLH) reveal that firstline etoposide-based therapy is m

Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

February 2024Lara C. Pullen, PhDResults from a contemporary standard-of-care study of patients with primary hemophagocytic lymphohistiocytosis (pHLH) reveal that firstline etoposide-based therapy is m
Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

by Teddy RosenbluthCredit: Unsplash/CC0 Public DomainAfter six years of painful injections, Stephanie Walker has had enough.Every 28 days, she drives an hour to Duke's Cancer center to get 50 mL s

Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

by Teddy RosenbluthCredit: Unsplash/CC0 Public DomainAfter six years of painful injections, Stephanie Walker has had enough.Every 28 days, she drives an hour to Duke's Cancer center to get 50 mL s
Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

byCell PressCredit: Pixabay/CC0 Public DomainHigh tumor mutational burden—the number of mutations found inside cancer cells—may not generalize as an accurate biomarker across diverse cancer pati
Starting cancer treatment? You should discuss fertility first

Starting cancer treatment? You should discuss fertility first

by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi

Starting cancer treatment? You should discuss fertility first

by Violet Kieu and Kate Stern,The ConversationCredit: AI-generated imageNot all Australians with cancer are getting the fertility care they need.In 2022, it is predicted more than 8,200 Australi
Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG
Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr
Refined method to peer into cancer cells' inner working unlocks the interactome

Refined method to peer into cancer cells' inner working unlocks the interactome

byJosep Carreras Leukaemia Research InstituteliCHi-C identifies cell types presumably implicated in disease etiology. A Enrichment of GWAS summary statistics at promoter-interacting regions (PIR

Refined method to peer into cancer cells' inner working unlocks the interactome

byJosep Carreras Leukaemia Research InstituteliCHi-C identifies cell types presumably implicated in disease etiology. A Enrichment of GWAS summary statistics at promoter-interacting regions (PIR
Pelvic lymph node radiation provides significant benefit for prostate cancer patients

Pelvic lymph node radiation provides significant benefit for prostate cancer patients

byAmerican Society for Radiation OncologyThe first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates,

Pelvic lymph node radiation provides significant benefit for prostate cancer patients

byAmerican Society for Radiation OncologyThe first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates,
Researchers discover compound that fights leukemia and lymphoma

Researchers discover compound that fights leukemia and lymphoma

JANUARY 12, 2024byUniversity of Texas at El PasoRenato Aguilera, Ph.D., a professor in the Department of Biological Sciences at The University of Texas at El Paso, is the principal investigator

Researchers discover compound that fights leukemia and lymphoma

JANUARY 12, 2024byUniversity of Texas at El PasoRenato Aguilera, Ph.D., a professor in the Department of Biological Sciences at The University of Texas at El Paso, is the principal investigator
Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance
Researchers identify path to prevent cognitive decline after radiation

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic
Obesity is increasing people's risk of cancer. Why?

Obesity is increasing people's risk of cancer. Why?

by Nancy Fliesler,Children's Hospital BostonAcomposite image representing a dormant breast tumor in the mammary fat pad of an obese mouse that is recruiting new blood vessels. Credit:

Obesity is increasing people's risk of cancer. Why?

by Nancy Fliesler,Children's Hospital BostonAcomposite image representing a dormant breast tumor in the mammary fat pad of an obese mouse that is recruiting new blood vessels. Credit: